1. Home
  2. SHIM vs NTHI Comparison

SHIM vs NTHI Comparison

Compare SHIM & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shimmick Corporation

SHIM

Shimmick Corporation

HOLD

Current Price

$4.27

Market Cap

149.2M

Sector

N/A

ML Signal

HOLD

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$4.58

Market Cap

139.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHIM
NTHI
Founded
1990
2008
Country
United States
United States
Employees
N/A
5
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.2M
139.1M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
SHIM
NTHI
Price
$4.27
$4.58
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
150.2K
85.8K
Earning Date
05-14-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
81.95
N/A
EPS
N/A
N/A
Revenue
$492,844,000.00
N/A
Revenue This Year
$13.99
N/A
Revenue Next Year
$6.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.63
N/A
52 Week Low
$1.58
$3.20
52 Week High
$6.76
$12.99

Technical Indicators

Market Signals
Indicator
SHIM
NTHI
Relative Strength Index (RSI) 58.03 44.72
Support Level $4.05 $4.17
Resistance Level $4.47 $5.78
Average True Range (ATR) 0.26 0.53
MACD 0.09 0.02
Stochastic Oscillator 91.38 24.57

Price Performance

Historical Comparison
SHIM
NTHI

About SHIM Shimmick Corporation

Shimmick Corp is engaged in delivering turnkey infrastructure solutions that strengthen critical markets across water, energy, climate resiliency, and sustainable transportation. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains critical infrastructure, including mass transit, bridges, and military infrastructure. The company has one operating and reportable segment: infrastructure solutions. All of its revenue is derived from the United States.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Share on Social Networks: